Combination Regimens of Radiation Therapy and Therapeutic Cancer Vaccines: Mechanisms and Opportunities

被引:24
|
作者
Garnett-Benson, Charlie [1 ]
Hodge, James W. [2 ]
Gameiro, Sofia R. [2 ]
机构
[1] Georgia State Univ, Dept Biol, Atlanta, GA USA
[2] NCI, Lab Tumor Immunol & Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
COLONY-STIMULATING FACTOR; CLASS-I ANTIGEN; TUMOR-CELLS; IONIZING-RADIATION; ANTITUMOR IMMUNITY; DENDRITIC CELLS; PHASE-I; IRRADIATION; IMMUNOTHERAPY; VACCINATION;
D O I
10.1016/j.semradonc.2014.07.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Radiation therapy (RI) is widely used with curative or palliative intent in the clinical management of multiple cancers. Although mainly aimed at direct tumor cell killing, mounting evidence suggests that radiation can alter the tumor to become an immunostimulatory milieu. Data suggest that the immunogenic effects of radiation can be exploited to promote synergistic antitumor effects in combination with immunotherapeutic agents. We review concepts associated with the immunogenic consequences of RI and highlight how preclinical findings are translating into clinical benefit for patients receiving combination regimens of RT and therapeutic cancer vaccines. Published by Elsevier Inc.
引用
收藏
页码:46 / 53
页数:8
相关论文
共 50 条
  • [31] Oxidative cell death in cancer: mechanisms and therapeutic opportunities
    An, Xiaoqin
    Yu, Wenfeng
    Liu, Jinbao
    Tang, Daolin
    Yang, Li
    Chen, Xin
    CELL DEATH & DISEASE, 2024, 15 (08):
  • [32] Semaphorins and their receptors in pancreatic cancer: Mechanisms and therapeutic opportunities
    Liu, Dahai
    Li, Jie
    Qi, Fei
    You, Hua
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [33] Cancer Chemoprevention and Piperine: Molecular Mechanisms and Therapeutic Opportunities
    Rather, Rafiq A.
    Bhagat, Madhulika
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2018, 6
  • [34] Advances in the development of therapeutic mRNA vaccines for cancer therapy
    Deng, Kexin
    Li, Xiaobin
    Liu, Wanwan
    Liu, Junyu
    Wang, Runming
    Yin, Yandong
    Zhang, Can Yang
    CHINESE SCIENCE BULLETIN-CHINESE, 2025, 70 (03): : 432 - 442
  • [35] Next-generation DC vaccines with an immunogenic trajectory against cancer: therapeutic opportunities vs. resistance mechanisms
    Sprooten, Jenny
    Garg, Abhishek D.
    GENES AND IMMUNITY, 2024, : 166 - 168
  • [36] Visible Blue Light' Therapy: Molecular Mechanisms'and Therapeutic Opportunities
    Garza, Z. C. Felix
    Born, M.
    Hilbers, P. A. J.
    van Riel, N. A. W.
    Liebmann, J.
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (40) : 5564 - 5577
  • [37] SETD2 in cancer: functions, molecular mechanisms, and therapeutic regimens
    Yawen Weng
    Jing Xue
    Ningning Niu
    Cancer Biology & Medicine, 2024, 21 (09) : 725 - 730
  • [38] SETD2 in cancer: functions, molecular mechanisms, and therapeutic regimens
    Weng, Yawen
    Xue, Jing
    Niu, Ningning
    CANCER BIOLOGY & MEDICINE, 2024, 21 (09) : 725 - 730
  • [39] Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
    Ruijuan Du
    Chuntian Huang
    Kangdong Liu
    Xiang Li
    Zigang Dong
    Molecular Cancer, 20
  • [40] Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
    Du, Ruijuan
    Huang, Chuntian
    Liu, Kangdong
    Li, Xiang
    Dong, Zigang
    MOLECULAR CANCER, 2021, 20 (01)